ClinicalTrials.gg
RecruitingNCT06673953Updated Nov 5, 2024

Effect of Respiratory Trainer on Cardiopulmonary Functions in Patients with Upper Cross Syndrome Post-Cardiac Surgery

An interventional study of Respiratory Muscle Training by (The Breather) and Traditional physical therapy program in Post Coronary Artery Bypass Grafting, Post-Cardiac Surgery Patients and Upper Cross Syndrome, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to male participants aged 45 Years to 55 Years. Per ClinicalTrials.gov, last updated 2024-11-05.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 9 months ago, but the record still lists the study as recruiting.
  • Started Aug 2024; still recruiting 2 years 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
45 Years to 55 Years
Sex
Male
01

Study summary

The purpose of this study is to investigate if there is any effect of the respiratory training on cardiopulmonary functions in patients with upper cross syndrome post-cardiac surgery.

Hypothesis:

Null hypothesis: There is no effect of the respiratory training on pulmonary functions in patients with upper cross syndrome post-cardiac surgery.

Read the detailed description

Sixty post-CABG-male-patients (n=60) with upper cross syndrome, their age ranges from 45 to 55 years old, are selected from Elbank-Elahly hospital (out-patient clinic), Cairo, Egypt. This randomized control study is performed after assessing and randomly assigning patients, (through using a computer program which generates random numbers), into two equal groups (30 patients for each group).

Respiratory training (study) group. Thirty patients (n=30) will receive respiratory muscles training and traditional physical therapy program for six weeks (three sessions/ week) for 40-60 minutes.

Traditional (control) group. Thirty patients (n=30) will receive the traditional physical therapy program for six weeks (three sessions/ week) for 40-60 minutes.

All subjects enrolled in the study are informed about the aim, technique, and experimental protocol of this study before participation. A written informed consent is assigned before participation.

After open-heart surgeries, patients with median sternotomy must restrict upper limbs movements that stretch the sternum, for 8 to 12 weeks after surgery, and avoid raising their arms above the head.

In addition, inappropriate posture such as forward head posture caused by the incision leads to upper cross syndrome. This causes an inability to perform activities of daily living, and chronic neck pain which adversely affects the respiratory system due to respiratory muscle imbalance.

Chronic neck pain (CNP), due to upper cross syndrome, is one of the most prevalent and costly musculoskeletal complaints associated with significant functional disability.

Equipment:

A. Evaluative equipment:

  1. Weight and height scales: To measure body weight and height to calculate BMI.
  2. Visual Analog Scale (VAS): To assess pain severity.
  3. Pressure biofeedback instrument: To measure endurance of deep cervical flexors (DCF).
  4. Electronic Spirometer: Digital-CONTEC-SP10-Spirometer-Lung-Breathing-Diagnostic-Vitalograph-Spirometry-Model CMS501 (Made in China), to measure ventilatory function test parameters.

    Forced expiratory volume in the first second (FEV1), Forced vital capacity (FVC), FEV1/FVC ratio. and Peak expiratory flow rate (PEFR).

  5. Pittsburgh Sleep Quality Index. To measure sleep quality (Arabic version)
  6. pulse oximetry. To measure HR, and SPO2 (Pulse Oximeter GRANZIA Model No: AS-304).
  7. Sphygmomanometer: To measure ABP (Model Number: GT001-110/111 aneroid sphygmomanometer, Zhejiang, China)
  8. Stopwatch. To measure six-minute walk test time.
  9. Short Form 36 (SF-36) Health Survey Questionnaire: To measure quality of life.

B. Treatment equipment:

  1. Respiratory muscle trainer device (The Breather device).
  2. DCF muscles training device: Pressure biofeedback (Stabilizer TM, Chattanooga Group, Inc., Chattanooga, TN)
  3. Gymna electrotherapy device.
  4. EME ultrasound-therapy device.
  5. A 650-W infrared halogen lamp (Philips Electronics Industries)

Procedure:

A. Evaluation Procedures: All patients will follow the same evaluative procedures before (baseline) and after 12 weeks of treatment. (illustrated in the Outcome Measures section)

B. Therapeutic procedures:

Respiratory training (study) group: Patients will receive:

  1. Respiratory muscles training: They will be asked to perform respiratory training through The Breather device beginning with the easiest setting. They will be instructed to inhale deeply and forcefully (at non fatigable resistance) for 2-3 seconds, slight pause, and then exhale forcefully for 2-3 seconds for 10 repetitions with 2 sets.
  2. Traditional physical therapy program in the form of:

    • TENS: Conventional TENS will be applied at high frequency (from 50 Hz to 130 Hz), low intensity (comfortable, not painful) and small pulse duration (50 μs to 200 μs). By applying small surface electrodes on the neck paraspinal muscles for 20 minutes.
    • Low-intensity continuous ultrasonic waves will be applied on the neck paraspinal muscles (trigger points of the trapezius muscles) for 10 minutes.
    • Infrared radiation application will be used for 10 minutes: The lamp should cover the area over the upper back and neck regions.
    • Cervical Stabilization exercise will be performed after three repetitions of stretching exercises for neck muscles as warm-up and cool-down exercises. Then, the exercise will be executed in supine position; the cuff will be put suboccipital. They will reach a 5mm Hg pressure target with increments of 2 mm Hg from a baseline of 20mm Hg to the ultimate level of 30mm Hg with hold for 10 seconds. The duration of contraction will gradually increase up to 10 seconds for each target level. Subjects will perform ten repetitions before progressing to the next target level.

Traditional (control) group: Patients will receive the traditional physical therapy program.

02

Conditions studied

  • Post Coronary Artery Bypass Grafting
  • Post-Cardiac Surgery Patients
  • Upper Cross Syndrome
  • Respiratory Muscle Weakness
  • Respiratory Muscle Training

Keywords

  • Post-CABG / Upper Cross Syndrome / Respiratory Muscle Training
03

In context

Oculocerebral hypopigmentation syndrome type Preus

37 studies on the registry are indexed under Oculocerebral hypopigmentation syndrome type Preus; 20 are open to participants now.

This study's planned enrollment of 60 is above the median of 48 across 34 interventional studies indexed under Oculocerebral hypopigmentation syndrome type Preus.

Browse Oculocerebral hypopigmentation syndrome type Preus studies →

Lead sponsor

Cairo University is the lead sponsor of 4,909 studies on the registry; 1,445 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 55 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Sixty post-CABG-male-patients for at least three months and their age ranges from 45 to 55 years old.
  • Craniovertebral angle \< 51°, but not less than 30°.
  • Non-specific chronic neck pain: defined as neck pain without an identifiable pathological cause and attributed to poor posture without radiation to upper limbs.
  • VAS score between 3-7.
  • Their body mass index ranges from (25 -29.9) kg/m2.
  • Values of FEV1 and FVC lower than 80%

Exclusion criteria

Exclusion Criteria:

  • Rheumatoid arthritis, cervical disc pathology, and traumatic neck pain.
  • History of respiratory disease and clinical signs of severe cardiac events.
  • Neurological disorders which affect the diaphragm.
  • Patients whose BMI is less than 25, or greater than 30 kg/m2.
  • Smokers.
  • Values of FEV1 and FVC higher than 80%
  • Patients with chronic obstructive pulmonary disease or asthma.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Respiratory training (study) group.

    Thirty patients (n=30) receiving respiratory muscles training and traditional physical therapy program for six weeks (three sessions/ week) for 40-60 minutes.

    Other: Respiratory Muscle Training by (The Breather) · Other: Traditional physical therapy program

  • Active comparator
    Traditional (control) group

    Thirty patients (n=30) receiving the traditional physical therapy program for six weeks (three sessions/ week) for 40-60 minutes.

    Other: Traditional physical therapy program

Interventions

  • OtherRespiratory Muscle Training by (The Breather)

    Patients are instructed to inhale deeply and forcefully (at non fatigable resistance) for 2-3 seconds, slight pause, and then exhale forcefully for 2-3 seconds for 10 repetitions with 2 sets.

    Also known as: Respiratory Muscle Training

  • OtherTraditional physical therapy program

    Traditional physical therapy program in form of: (TENS / Low-intensity continuous ultrasonic / Infrared radiation application / Cervical Stabilization exercise )

    Also known as: Conventional physical therapy program

06

What researchers measure

Primary outcomes

  1. Pulmonary functions:

    Measurements of ventilatory function are recorded before and after receiving the treatment sessions (FEV1, FVC, FEV1/FVC, MVV). Assessing respiratory improvement. Unit of Measure: Liters (L)

    Time frame: Baseline (assessment), and at 12 weeks post-intervention.

  2. Six-Minute-Walk Test

    Patients are asked to walk for 6 minutes along a flat corridor. Measured in meters, assessing exercise capacity and functional improvement. The SpO2 and heart rate are measured continuously during testing. Heart Rate (HR): Measured in beats per minute (BPM), evaluating cardiovascular response. SpO2 (Peripheral Oxygen Saturation): Assessing: Blood oxygen saturation levels to evaluate respiratory and cardiovascular efficiency. Unit of Measure: Percentage (%)

    Time frame: Baseline (assessment), and at 12 weeks post-intervention.

  3. VO2 max (Maximal Oxygen Consumption)

    Assessing: Maximum oxygen uptake during high-intensity exercise to evaluate aerobic capacity and cardiopulmonary function. Estimated based on an equation which contains: weight is body weight (kg), 6MWD is distance walked in 6 min (m), age (years), BMI is calculated body mass index(kg/m2), height is body height (cm) and HR is heart rate at the end of the walking test. Unit of Measure: mL/kg/min

    Time frame: Baseline (assessment), and at 12 weeks post-intervention.

  4. Pittsburgh Sleep Quality Index.

    Respondents are asked to indicate how frequently they have experienced certain sleep difficulties and rate them. Scores for each question range from 0 to 3, with higher scores indicating more acute sleep disturbances.

    Time frame: Baseline (assessment), and at 12 weeks post-intervention.

  5. Short Form 36 (SF-36) Health Survey Questionnaire (Arabic version).

    A 36-item scale measures eight domains of health status. The scores are transformed to range from zero where the respondent has the worst possible health to 100 where the respondent is in the best possible health.

    Time frame: Baseline (assessment), and at 12 weeks post-intervention.

  6. Pain severity

    Assessing intensity of perceived pain for monitoring changes in pain severity throughout the intervention. Pain severity is assessed by the self-reported Visual Analog Scale (VAS). By using a 10 cm line where patients mark their pain level, with 0 representing "no pain" and 10 representing "worst imaginable pain." Unit of Measure: Points on a 0-10 scale

    Time frame: Baseline (assessment), and at 12 weeks post-intervention.

  7. Endurance of DCF

    Endurance of DCF muscles is measured by a pressure biofeedback instrument. The patient lays in the crook lying position and the pressure biofeedback instrument is placed under the neutral cervical spine below the occiput and inflated up to 20 mmHg. The subjects perform this movement at 5 different pressure levels, i.e., 22, 24, 26, 28, and 30 mmHg. Each level is supposed to be held for 10 sec, and the test terminated if they are unable to hold the position for 10 sec at any level or if the maximum level is achieved (30 mmHg).

    Time frame: Baseline (assessment), and at 12 weeks post-intervention.

  8. Craniovertebral angle measurement

    Adhesive markers are placed on the tragus of the right ear and the C7 spinous process, and the subjects are instructed to stand by side (lateral view) and to look at a target in front of them with both arms beside the body. Then, a digital camera is fixed at the level of the 7th cervical vertebra. Finally, the Surgi map Spine software is used to analyze the digitalized photographs and measure CVA. It is the angle between 2 imaginary lines: the horizontal line passing through the spinous process of C7 and the line passing from C7 to the tragus of the ear.

    Time frame: Baseline (assessment), and at 12 weeks post-intervention.

  9. Weight and height measurement

    Weight and height are recorded, and BMI will be calculated according to the formula: BMI = Weight (Kg) / Height (m2)

    Time frame: Baseline (assessment)

07

Study locations

1 of 1 sites recruiting
  • Faculty of Physical Therapy, Cairo University
    Giza, Giza Governorate 11432, Egypt
    • Faculty of Physical Therapy, Cairo University · Contact · Info@pt.cu.edu.eg · 02 37617691
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06673953
Lead sponsor
Cairo University
Responsible party
Mostafa ali (Assistant Lecturer, Cairo University) — Principal investigator
First posted
Nov 5, 2024
Start date
Aug 28, 2024
Primary completion
Jan 20, 2025 (estimated)
Completion
Feb 25, 2025 (estimated)
Last update
Nov 5, 2024

Study contacts

Mostafa Ali
Contact
mostafaaly.atia@gmail.com
+201004580951
Zeinab Helmy, Professor
study chair · Professor of Physical Therapy for Cardiovascular / Respiratory Disorder and Geriatrics. Faculty of Physical Therapy. Cairo University
El-Sayed Felaya, Lecturer
study director · Lecturer of Physical Therapy for Cardiovascular / Respiratory Disorder and Geriatrics. Faculty of Physical Therapy. Cairo University
Ahmed Elsisi, Assistant Professor
study director · Assistant Professor of Critical Care Medicine. Faculty of Medicine. Beni suef University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion